Watchlist Price Alert

Intellia Therapeutics Inc... (NTLA)

NASDAQ: NTLA · Real-Time Price · USD

8.34

-0.21 (-2.46%)

At close: May 13, 2025, 3:59 PM

8.50

1.98%

Pre-market: May 14, 2025, 06:11 AM EDT

Intellia Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	57.88M	36.27M	52.12M	33.05M	57.99M	43.1M	30.43M	26.12M	16.48M
Cost of Revenue	n/a	8.98M	7.57M	6.89M	150.41M	108.41M	89.11M	67.65M	31.84M
Gross Profit	47.59M	27.3M	44.55M	26.16M	-92.41M	-65.31M	-58.68M	-41.53M	-15.36M
Operating Income	-534.26M	-515.29M	-458.16M	-267.85M	-136.58M	-106.37M	-90.87M	-69.56M	-32.16M
Interest Income	47.81M	49.83M	8.54M	1.28M	2.35M	6.83M	5.53M	2.01M	525K
Pretax Income	-519.02M	-481.19M	-474.19M	-267.89M	-134.23M	-99.53M	-85.34M	-67.54M	-31.63M
Net Income	-519.02M	-481.19M	-490.21M	-259.72M	-125.57M	-92.7M	-85.34M	-67.54M	-31.63M
Selling & General & Admin	125.83M	116.5M	90.31M	71.1M	44.17M	41.06M	32.19M	28.02M	16.8M
Research & Development	466.31M	435.07M	419.98M	229.81M	150.41M	108.41M	89.11M	67.65M	31.84M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	592.14M	551.57M	510.29M	300.9M	194.58M	149.47M	121.3M	95.67M	48.64M
Interest Expense	n/a	n/a	8.54M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	592.14M	551.57M	510.29M	300.9M	194.58M	149.47M	121.3M	95.67M	48.64M
Income Tax Expense	n/a	n/a	16.02M	-8.17M	-8.66M	-6.83M	5.53M	-2.99M	-1.1M
Shares Outstanding (Basic)	98.85M	88.77M	76.97M	70.89M	55.99M	47.25M	43.07M	36.01M	22.22M
Shares Outstanding (Diluted)	98.85M	88.77M	76.97M	70.89M	55.99M	47.25M	43.07M	36.01M	22.22M
EPS (Basic)	-5.25	-5.42	-6.37	-3.66	-2.24	-1.96	-1.98	-1.88	-1.42
EPS (Diluted)	-5.25	-5.42	-6.37	-3.66	-2.24	-1.96	-1.98	-1.88	-1.42
EBITDA	-523.98M	-506.31M	-450.59M	-260.96M	-130.27M	-100.78M	-86.41M	-66.56M	-31.05M
EBIT	-534.26M	-515.29M	-458.16M	-267.85M	-136.58M	-106.37M	-90.87M	-69.56M	-32.16M
Depreciation & Amortization	10.29M	8.98M	7.57M	6.89M	6.31M	5.59M	4.46M	2.99M	1.1M